Search Results
365 results
Your search is now limited to «Pancreatic Cancer» expert search.
GlobeNewswire 01/22/2019 07:30
Overall Response Rate of 38% Observed in the First 24 Patients Who Had At Least One Scan on Treatment. Overall Response Rate of 38% Observed in the First 24 Patients Who Had At Least One Scan on Treatment.
More from GlobeNewswire:
ENDPOINTS 01/22/2019 06:47
AbbVie, J&J concede a failure for blockbuster Imbruvica in their PhIII shot at pancreatic cancer – Endpoints News.
More from ENDPOINTS:
Comparison of neoadjuvant therapy and upfront surgery in resectable pancreatic cancer: a meta-analysis and systematic review.
More from International Journal of COPD:
Onclive 01/21/2019 16:29
Michael Choti, MD Although the goal is to cure patients with pancreatic cancer through surgery, many patients who present with this disease are ineligible for resection at the time of diagnosis, making imaging and early detection imperative, said Michael A. Choti, MD.
More from Onclive:
Medindia.com 01/20/2019 05:43
People at high risk of pancreatic cancer can be identified earlier before the disease reaches advanced and difficult to treat stages by a new screening test.
More from Medindia.com:
WN.com 01/19/2019 04:10
A new approach to pancreatic cancer screening may help doctors detect the disease in people who are at high risk before it reaches more advanced stages and becomes difficult to treat.
More from WN.com:
PR Newswire 01/18/2019 16:29
AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Metastatic Pancreatic Cancer.
More from PR Newswire:
ClinicalTrials.gov 01/18/2019 12:00
Third, the participants were basically divided into three groups,cases with pancreatic cancer, cases with other pancreatic diseases, and health volunteers.
More from ClinicalTrials.gov:
Pancreatic Cancer Action 01/18/2019 11:32
However, the majority of pancreatic cancer cases are diagnosed at a late stage and therefore this is a target that is not very achievable for pancreatic cancer.
More from Pancreatic Cancer Action:
FeedNavigator 01/17/2019 12:56
The pathogenesis of T3cDM is explained which is often linked to the history of chronic pancreatitis, pancreatic cancer.
More from FeedNavigator:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications